[HTML][HTML] The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention
S Domínguez-Zorita, JM Cuezva - Cancers, 2023 - mdpi.com
… whereas OXPHOS prevails in differentiated cells [180,181]. Interestingly, IF1 also plays a
relevant role in metabolic reprogramming during differentiation of human mesenchymal stem …
relevant role in metabolic reprogramming during differentiation of human mesenchymal stem …
[HTML][HTML] MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response
V González-Quintana, L Palma-Berré… - Oncology …, 2016 - spandidos-publications.com
… -positive patients and in less-differentiated tumors (31). Kaplan-… As therapeutic agents,
miRNAs were employed to enhance … damage repair and cell cycle progression targets (41–43). …
miRNAs were employed to enhance … damage repair and cell cycle progression targets (41–43). …
Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative …
F Yang, Wendusubilige, J Kong, Y Zong, M Wang… - EPMA Journal, 2023 - Springer
… patients who were sensitive to antioxidant therapy to conduct differential gene functional
enrichment analysis and predict potential therapeutic drugs. Diagnostic markers between …
enrichment analysis and predict potential therapeutic drugs. Diagnostic markers between …
ERα inhibits mesenchymal and amoeboidal movement of liver cancer cell via Gα12
J Yun, YS Kim, MJ Heo, MJ Kim… - … Journal of Cancer, 2022 - Wiley Online Library
… , and consequent better survival rates observed in females, supporting the idea that modulating
the ERα-Gα12 pathway may be utilized for sex differential approaches in HCC treatment. …
the ERα-Gα12 pathway may be utilized for sex differential approaches in HCC treatment. …
Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis
… can only be provided when the incidence of the disease is diagnosed in the early stages, …
disease progression since they are involved in essential processes such as cell differentiation, …
disease progression since they are involved in essential processes such as cell differentiation, …
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape
… TNBC treatment discovered in early translational studies. We focus on cancer cell membrane
molecules, hyperactive intracellular signaling pathways, and the tumor microenvironment (…
molecules, hyperactive intracellular signaling pathways, and the tumor microenvironment (…
Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers
V Aggarwal, K Priyanka, HS Tuli - Molecular diagnosis & therapy, 2020 - Springer
… In addition, they are also important in cell development and differentiation, tumor proliferation,
and apoptosis. More than 2000 miRNAs have been found to be associated with numerous …
and apoptosis. More than 2000 miRNAs have been found to be associated with numerous …
A micro-RNA expression signature for human NAFLD progression
… association of the small RNA and the treatment response. Because an ordinal regression …
RNAs identified in our analysis exhibited differential abundance patterns that were specific …
RNAs identified in our analysis exhibited differential abundance patterns that were specific …
[HTML][HTML] A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease
Y Liu, D Huang, Z Li, LF Zhou, T Cen, B Wei… - Frontiers in …, 2023 - frontiersin.org
… Aims: The pathogenesis of disease progression targets for … Guidelines for the diagnosis and
treatment of acute and chronic … By using differential analysis, when P < 0.05, the differential …
treatment of acute and chronic … By using differential analysis, when P < 0.05, the differential …
[HTML][HTML] … Bioinformatics Analysis on the Role of Long Non-Coding RNAs as Drivers and Gatekeepers of Androgen-Independent Prostate Cancer Using LNCaP and PC …
M Mbeje, J Kandhavelu, C Penny… - Current Issues in …, 2023 - mdpi.com
… functions such as cell differentiation, development, and the cell … cancers and aid their
resistance to cancer therapies [25]. Hsa-miR-… The cancer progression targets are shown in green …
resistance to cancer therapies [25]. Hsa-miR-… The cancer progression targets are shown in green …
相关搜索
- targets for therapeutic intervention cancer progression
- disease progression potential novel treatment targets
- prostate cancer progression diagnosis and treatment
- breast cancer targeted therapy
- disease treatment and management
- treatment of triple negative breast cancer
- ovarian cancer management mirna target
- early breast cancer diagnosis therapy prediction
- therapeutic targets clinical biomarkers
- micrornas in cervical cancer therapeutic application
- tumor immune landscape therapeutic opportunities
- cervical cancer pathogenesis targeted therapy
- treatment response cervical cancer development
- disease progression plasma proteomic approach
- prostate cancer progression noncoding rna
- disease progression patients with heart failure